Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosisAdi Mor, Michal Segal Salto, Avi Katav, Neta Barashi, Victoria Edelshtein, Mirko Manetti, Yair Levi, Jacob George, Marco Matucci-Cerinic
12 August 2019
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort studyMuriel Elhai, Marouane Boubaya, Oliver Distler, Vanessa Smith, Marco Matucci-Cerinic, Juan José Alegre Sancho, Marie-Elise Truchetet, Yolanda Braun-Moscovici, Florenzo Iannone, Pavel I Novikov, Alain Lescoat, Elise Siegert, Ivan Castellví, Paolo Airó, Serena VettoriSee the full list of authors
12 June 2019
Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosisSu-Jin Moon, Jung Min Bae, Kyung-Su Park, Ilias Tagkopoulos, Ki-Jo Kim
14 May 2019
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosisNava Ferdowsi, Molla Huq, Wendy Stevens, Marie Hudson, Mianbo Wang, Tien Tay, Jodie L Burchell, Sam Mancuso, Candice Rabusa, Vijaya Sundararajan, David Prior, Susanna M Proudman, Murray Baron, Mandana Nikpour, See the full list of authors
14 May 2019
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohortWanlong Wu, Suzana Jordan, Nicole Graf, Janethe de Oliveira Pena, John Curram, Yannick Allanore, Marco Matucci-Cerinic, Janet E Pope, Christopher P Denton, Dinesh Khanna, Oliver Distler, , EUSTAR Collaborators, Marco Matucci-Cerinic, Serena GuiducciSee the full list of authors
12 April 2019